Injectsense, Inc.

Emeryville, CA · Founded 2014 · Medtech · Private

iOP-Connect system: a miniaturized implantable intraocular pressure sensor with integrated MEMS, ASIC, microbattery, and telemetry for continuous glaucoma monitoring

Claim this profile

Follows are private to you and power your alerts

Updated · injectsense.com

Sector
Medtech
Headquarters
Emeryville, CA
Founded
2014
Latest Form D
$4.1M, Apr 2019
Total capital
$16.2M
Federal grants
$2.2M
2 awards · 2022–2023
Rank in peer group#510 of 538
Private capital raised
$13.9M
2 Form D · last Apr 2019
90 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
9 pending · first 2021
Rank in peer group#237 of 538

Capital timeline

2017201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $16.2M$1.6M$624K1st Form D$9.8M2nd Form D$4.1M
2017201920212023FEDERAL ↑EQUITY ↓Cumulative $16.2M$1.6M$624K2nd Form D$4.1M

Latest events

  • Federal grantHealth and Human S · Phase II · iOP-Connect System for Long-Term Continuous Monitoring of Glaucoma Therapy by means of an Implantable Autonomous Intraocular Pressure Sensor$624K
  • Federal grantHealth and Human S · Phase II · iOP-Connect System for Long-Term Continuous Monitoring of Glaucoma Therapy by means of an Implantable Autonomous Intraocular Pressure Sensor$1.6M
  • Private capital raisedForm D · SEC · 2nd filing$4.1M
  • Private capital raisedForm D · SEC · 1st filing$9.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#237 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Ariel CaoResearcherExecutive Officer, DirectorLinked by 1 patent
  • Enrique MalaretExecutive Officer, DirectorNamed in SEC Form D filings
  • Zack ScottDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 10
  • PendingSmart Implantable Micro Device For Therapeutic Active Flow Control And Associated Systems And Methods For UseUSPTOApplication 18134988
  • PendingCircadian Intraocular Pressure Profile and Methods of TreatmentUSPTOApplication 17688408
  • PendingMethods and Devices for Implantation of Intraocular Pressure SensorsUSPTOApplication 17550160
Show all 10 patent records
  • Smart Implantable Micro Device For Therapeutic Active Flow Control And Associated Systems And Methods For UseDec 7, 2023 · Application 18134988Pending
  • Circadian Intraocular Pressure Profile and Methods of TreatmentSep 8, 2022 · Application 17688408Pending
  • Methods and Devices for Implantation of Intraocular Pressure SensorsJul 7, 2022 · Application 17550160Pending
  • Hermetic Heterogeneous Integration Platform for Active and Passive Electronic ComponentsApr 21, 2022 · Application 17566930Pending
  • Hermetically Sealed Implant Sensors With Vertical Stacking ArchitectureJul 1, 2021 · Application 17199858Pending
  • Hermetically Sealed Implant Sensors With Vertical Stacking ArchitectureApr 13, 2021 · US 10,973,425Granted
  • Methods And Devices For Implantation Of Intraocular Pressure SensorsApplication PCTUS2015038862Pending
  • Circadian Intraocular Pressure Profile and Methods of TreatmentApplication 63158073Pending
  • Hermetic Heterogeneous Integration Platform for Active and Passive Electronic ComponentsApplication 62870243Pending
  • Smart Implantable Micro Device For Therapeutic Active Flow Control And Associated Systems And Methods For UseApplication PCTUS2023018713Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .